COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 eraAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22022-11-0133OA
Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant RecipientsTRANSPLANTATIONIF52022-08-0413OA
Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients尼马曲韦/利托那韦治疗实体器官移植受者新型冠状病毒肺炎的早期临床经验AMERICAN JOURNAL OF TRANSPLANTATIONIF8.22022-08-0169OA
Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressantsAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22022-07-0166PRE